Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87451 refers to a laboratory test designed to detect infectious agent antigens in blood and other body fluids through various immunoassay techniques. This code encompasses qualitative or semiquantitative testing methods, which include enzyme immunoassay (EIA), enzyme-linked immunosorbent assay (ELISA), fluorescence immunoassay (FIA), and immunochemiluminometric assay (IMCA). These techniques utilize labeled antibodies that specifically bind to the target antigens present in the patient sample. The EIA and ELISA methods are particularly notable for their ability to detect minute quantities of antigens due to the use of a secondary enzyme-labeled antibody, which facilitates a chromogenic reaction resulting in a visible color change or fluorescence. This allows for the measurement of the infectious agent's presence in a qualitative or semiquantitative manner. The FIA method employs a fluorescent compound to indicate the binding of the detection antibody to the analyte, while the IMCA method utilizes a light emission device to quantify the antigen-antibody complex through chemiluminescence. It is important to note that code 87451 is specifically used for reporting polyvalent testing, which involves multiple organisms, with each polyvalent antiserum being utilized to identify serological subtypes of specific organisms that may have various strains present. For organisms that do not have a specific code for reporting, code 87449 should be used instead.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 87451 is indicated for use in the detection of infectious agent antigens in various clinical scenarios. The following conditions may warrant the use of this testing method:
The procedure for conducting the test under CPT® Code 87451 involves several key steps, which are outlined as follows:
After the completion of the testing procedure associated with CPT® Code 87451, the following post-procedure considerations are important:
Results are typically reviewed and interpreted by a qualified healthcare professional, who will communicate the findings to the patient or referring physician. Depending on the results, further diagnostic testing or treatment may be recommended. It is essential to ensure that the results are documented accurately in the patient's medical record for future reference and continuity of care. Additionally, any necessary follow-up actions, such as retesting or additional investigations, should be planned based on the findings of the immunoassay test.
| Short Descr | POLYVALENT MULT ORG EA AG IA | Medium Descr | IAAD IA POLYV MLT ORGANISMS EA POLYV ANTISERUM | Long Descr | Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; polyvalent for multiple organisms, each polyvalent antiserum | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2022-01-01 | Changed | First appearance of change in codebook. |
| 2022-01-01 | Note | Grammatical correction. |
| 2021-01-01 | Changed | First appearance of change in CPT® Code Set. |
| 2020-10-06 | Changed | Code description changed. |
| 2016-01-01 | Changed | Description Changed |
| 2011-01-01 | Changed | Short description changed. |
| 2001-01-01 | Added | First appearance in code book in 2001. |
Get instant expert-level medical coding assistance.